New 'smart' nanoparticles help the immune system better attack tumors

Researchers at the University of Adelaide have developed a novel application of mRNA technology designed to reprogram immune cells that typically support tumor growth. The approach targets specific immune populations within the tumor microenvironment, converting them from cancer-promoting agents into active participants in the body’s natural defense system. By delivering customized mRNA sequences directly to these cells, the method aims to enhance the immune system’s ability to recognize and eliminate malignant tissue.

The research adapts established mRNA platforms to address a persistent challenge in oncology: the presence of immune cells that suppress anticancer activity. According to the study, the engineered mRNA molecules instruct tumor-associated cells to express proteins that shift their functional role, thereby amplifying targeted immune responses and improving tumor clearance in experimental models. The